EPHA2 and VEGFA activate both PI3K/AKT and the extracellular signal-regulated kinase 1/2 (ERK1/2) signaling pathways to induce tumor progression by increasing tumor cell proliferation and vasculogenic mimicry [68]. The gene discussed is EPHA2; the disease is neoplasm.